ctrl K

Watchlist Price Alert

Navidea Biopharmaceutical... (NAVB)

OTC: NAVB · Real-Time Price · USD

0.00

-0.00 (-100.00%)

At close: Apr 04, 2025, 10:19 AM

Navidea Biopharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	65.65K	531.51K	915.01K	26.62K	322.52K	1.81M	21.97M
Cost of Revenue	184.95K	198.83K	1.05K	6.67K	96.64K	3.65K	2.3M
Gross Profit	-119.3K	332.68K	913.97K	19.95K	225.88K	1.81M	19.67M
Operating Income	-14.05M	-12.06M	-10.71M	-10.96M	-10.85M	-13.88M	-2.22M
Interest Income	n/a	6K	11.34K	25K	n/a	n/a	n/a
Pretax Income	-15.18M	-11.71M	-10.72M	-10.94M	-16.17M	-17.79M	-14.31M
Net Income	-15.18M	-11.73M	-10.64M	-10.95M	-16.13M	74.95M	-14.31M
Selling & General & Admin	7.96M	7.45M	6.69M	6.28M	7.7M	11.17M	13.01M
Research & Development	5.97M	5.14M	4.93M	5.34M	4.22M	4.51M	8.88M
Other Expenses	n/a	-14.12K	-21.86K	-631.21K	1.15K	n/a	n/a
Operating Expenses	13.93M	12.59M	11.63M	10.98M	11.07M	15.68M	21.9M
Interest Expense	1.1M	6.36K	n/a	25.29K	30.8K	168.97K	4.87K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	14.12M	12.59M	11.63M	10.99M	11.17M	15.69M	24.19M
Income Tax Expense	n/a	16.04K	-81.74K	707.00	2.75K	-4.06M	-648K
Shares Outstanding (Basic)	29.34M	29.34M	23.9M	14.39M	8.53M	8.08M	7.77M
Shares Outstanding (Diluted)	30.9M	29.34M	23.9M	14.39M	8.53M	8.3M	7.77M
EPS (Basic)	-0.59	-0.4	-0.45	-0.76	-1.89	9.40	-1.84
EPS (Diluted)	-0.56	-0.4	-0.45	-0.76	-1.89	9.00	-1.84
EBITDA	-13.88M	-11.51M	-10.64M	-10.82M	-10.85M	-13.14M	-6.87M
EBIT	-14.08M	-11.71M	-10.71M	-10.96M	-10.85M	-13.88M	-7.37M
Depreciation & Amortization	95.82K	198.83K	190.58K	144.51K	150.38K	254.59K	501.37K